UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

COVID-19 and myositis – unique challenges for patients

Rheumatology (Oxford, England), 2021-02, Vol.60 (2), p.907-910

2021

Volltextzugriff (PDF)

Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre

Rheumatology (Oxford, England), 2021-07, Vol.60 (7), p.3398-3403

2021

Volltextzugriff (PDF)

Pitfalls in the diagnosis of myositis

Best practice & research. Clinical rheumatology, 2020-02, Vol.34 (1), p.101486-101486, Article 101486

2020

Volltextzugriff (PDF)

Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity

Annals of the Rheumatic Diseases, 2015-05, Vol.74 (5), p.795-798

2015

Volltextzugriff (PDF)

Advances in the early diagnosis and therapy of inclusion body myositis

Current opinion in rheumatology, 2018-11, Vol.30 (6), p.644-649

Lilleker, James B

2018

Volltextzugriff (PDF)

Can machine learning unravel the complex IIM spectrum?

Nature reviews. Rheumatology, 2020-06, Vol.16 (6), p.299-300

2020

Volltextzugriff (PDF)

Rapamycin for inclusion body myositis: targeting non-inflammatory mechanisms

Rheumatology (Oxford, England), 2019-03, Vol.58 (3), p.375-376

2019

Volltextzugriff (PDF)

[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis

Annals of the rheumatic diseases, 2019-05, Vol.78 (5), p.657

2019

Volltextzugriff (PDF)

Glutamic acid decarboxylase (GAD) antibodies in epilepsy: Diagnostic yield and therapeutic implications

Seizure (London, England), 2014-09, Vol.23 (8), p.598-602

2014

Volltextzugriff (PDF)

The perils of myositis mimickers with illustrative case reports

Clinical and experimental rheumatology, 2022-02, Vol.40 (2), p.366

2022

Volltextzugriff (PDF)

Epidemiology of the idiopathic inflammatory myopathies

Nature reviews. Rheumatology, 2023-11, Vol.19 (11), p.695-712

2023

Volltextzugriff (PDF)

Long‐term strength and functional status in inclusion body myositis and identification of trajectory subgroups

Muscle & nerve, 2020-07, Vol.62 (1), p.76-82

2020

Volltextzugriff (PDF)

Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups

Nature reviews. Rheumatology, 2024-05, Vol.20 (5), p.313-314

2024

Volltextzugriff (PDF)

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort

Rheumatology (Oxford, England), 2019-03, Vol.58 (3), p.468-475

2019

Volltextzugriff (PDF)

The successful use of tocilizumab as third-line biologic therapy in a case of refractory anti-synthetase syndrome

Rheumatology (Oxford, England), 2016-12, Vol.55 (12), p.2277-2278

2016

Volltextzugriff (PDF)

Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: key points to prevent misdiagnosis

Rheumatology (Oxford, England), 2022-04, Vol.61 (4), p.1645-1650

2022

Volltextzugriff (PDF)

SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature

Neuromuscular disorders : NMD, 2022-10, Vol.32 (10), p.785-789

2022

Volltextzugriff (PDF)

Improved outcomes with early immunosuppression in patients with immune-checkpoint inhibitor induced myasthenia gravis, myocarditis and myositis: a case series

Supportive care in cancer, 2023-09, Vol.31 (9), p.518-518, Article 518

2023

Volltextzugriff (PDF)

Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment

Practical neurology, 2023-06, Vol.23 (3), p.222

2023

Volltextzugriff (PDF)

Genetics in inclusion body myositis

Current opinion in rheumatology, 2017-11, Vol.29 (6), p.639-644

2017

Volltextzugriff (PDF)

Neurological Manifestations of Influenza Infection in Children and Adults: Results of a National British Surveillance Study

Clinical infectious diseases, 2014-03, Vol.58 (6), p.775-784

2014

Volltextzugriff (PDF)

Perspectives on glucocorticoid usage in patients with adult inflammatory myopathy

Clinical rheumatology, 2021-12, Vol.40 (12), p.4977-4982

2021

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(121)
Mit Volltextzugriff
(120)

Publikationsform

Sprache

Englisch
(131)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

COVID-19 and myositis – unique challenges for patients

Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre

Pitfalls in the diagnosis of myositis

Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity

Advances in the early diagnosis and therapy of inclusion body myositis

Can machine learning unravel the complex IIM spectrum?

Rapamycin for inclusion body myositis: targeting non-inflammatory mechanisms

[18F]Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis

Glutamic acid decarboxylase (GAD) antibodies in epilepsy: Diagnostic yield and therapeutic implications

The perils of myositis mimickers with illustrative case reports

Epidemiology of the idiopathic inflammatory myopathies

Long‐term strength and functional status in inclusion body myositis and identification of trajectory subgroups

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy

Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups

272nd ENMC international workshop: 10 Years of progress - revision of the ENMC 2013 diagnostic criteria for inclusion body myositis and clinical trial readiness. 16–18 June 2023, Hoofddorp, The Netherlands

The performance of the European League Against Rheumatism/American College of Rheumatology idiopathic inflammatory myopathies classification criteria in an expert-defined 10 year incident cohort

The successful use of tocilizumab as third-line biologic therapy in a case of refractory anti-synthetase syndrome

Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: key points to prevent misdiagnosis

SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature

Improved outcomes with early immunosuppression in patients with immune-checkpoint inhibitor induced myasthenia gravis, myocarditis and myositis: a case series

Nitrous oxide-induced subacute combined degeneration of the cord: diagnosis and treatment

Genetics in inclusion body myositis

Neurological Manifestations of Influenza Infection in Children and Adults: Results of a National British Surveillance Study

COVID‐19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies

Perspectives on glucocorticoid usage in patients with adult inflammatory myopathy

Suchergebnisse filtern